All Terrain Financial Advisors’s AbbVie ABBV Stock Holding History

All Terrain Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$151K	Hold	600	–	–	0.02%	142
2026 Q1	$130K	Buy	+600	New	+$133K	0.03%	132
2025 Q4	–	Sell	-600	Closed	-$139K	–	128
2025 Q3	$139K	Buy	+600	New	+$122K	0.03%	130
2021 Q1	–	Sell	-1,200	Closed	-$129K	–	87
2020 Q4	$129K	Hold	1,200	–	–	0.05%	89
2020 Q3	$105K	Sell	1,200 -2,300	-66%	-$217K	0.04%	89
2020 Q2	$344K	Sell	3,500 -200	-5%	-$17.6K	0.14%	68
2020 Q1	$282K	Sell	3,700 -400	-10%	-$34.1K	0.11%	92
2019 Q4	$363K	Buy	4,100 +1,200	+41%	+$99.6K	0.12%	98
2019 Q3	$219K	Buy	2,900 +2,300	+383%	+$158K	0.07%	146
2019 Q2	$44K	Sell	600 -1,000	-63%	-$78.6K	0.02%	191
2019 Q1	$129K	Buy	1,600 +600	+60%	+$49.1K	0.04%	181
2018 Q4	$92K	Buy	1,000 +100	+11%	+$8.79K	0.04%	163
2018 Q3	$85K	Hold	900	–	–	0.03%	193
2018 Q2	$83K	Hold	900	–	–	0.04%	202
2018 Q1	$85K	Hold	900	–	–	0.04%	200
2017 Q4	$87K	Buy	+900	New	+$84.8K	0.04%	209

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

All Terrain Financial Advisors's ABBV Position: Q2 2026 in Review

All Terrain Financial Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 9,550 shares worth $2.4M. The position accounts for 0.39% of the portfolio, ranked #44.

All Terrain Financial Advisors first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.88M in Q3 2018. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

All Terrain Financial Advisors held 9,550 shares of AbbVie worth $2.4M as of Q2 2026.
All Terrain Financial Advisors left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.39% of All Terrain Financial Advisors's portfolio in Q2 2026, its #44 holding.
All Terrain Financial Advisors first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
All Terrain Financial Advisors's AbbVie position peaked at $3.88M in Q3 2018.
4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on All Terrain Financial Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.